Posts Tagged ‘Pear Therapeutics’
Update on the aducanumab (Aduhelm) saga, retirement, financial advice, cognitive health, excessive worrying, neurotech, and more
Welcome to a new edition of SharpBrains’ e‑newsletter, providing this time a summary of the saga around the FDA approval of aducanumab (Aduhelm) as a supposed treatment for Alzheimer’s Disease, plus a range of timely research findings and resources for lifelong brain health. First, below are some key reads to navigate “probably the worst drug approval…
Read MorePrescription software firm Pear Therapeutics to go public via $1.6 billion SPAC deal, harnessing 3 FDA-authorized products and 14 candidates
Pear Therapeutics to Go Public in Roughly $1.6 Billion SPAC Deal (The Wall Street Journal): Medical technology company Pear Therapeutics Inc. has agreed to go public by merging with a blank-check company with ties to the Pritzker Vlock Family Office, betting on the growing role of prescription digital therapeutics. The proposed merger would give the…
Read MoreOn centenarians, memory, Mars, tDCS, ADHD, digital health, beautiful brains, and more
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring ten timely resources and research findings for lifelong brain and mental fitness. #1. Let’s start with a fascinating story and study :-) Study with 330 centenarians finds that cognitive decline is not inevitable … (Henne Holstege, PhD, assistant professor at Amsterdam University Medical Center) said her interest in researching…
Read MoreOhio joins Indiana and Kentucky in funding Pear Therapeutics’ digital addiction treatments
Ohio is third state to fund Pear’s digital therapeutics to tackle addiction (pharmaforum): The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear said that the Ohio Department of Mental Health and Addiction Services (OhioMHAS) and RecoveryOhio are providing access to…
Read MoreFrom digital therapeutics to personalized mental health solutions: Pear Therapeutics expands platform via partnerships with Empatica, etectRx, KeyWise, and Winterlight
Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Sensor-Based Technologies (press release): Pear Therapeutics, Inc. announced today that it has entered into agreements with multiple technology companies, including Empatica Inc., etectRx, Inc., and KeyWise, Inc. The new technologies complement the voice-based biomarkers previously licensed from Winterlight Labs. These new agreements bolster Pear’s…
Read MoreUpdate: Understanding Brain Health via Cosmological Health, and vice versa
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring fascinating findings, books and resources for lifelong brain health. #1. “The human brain (section; left image above) functions thanks to its wide neuronal network that is deemed to contain approximately 69 billion neurons. On the other hand, the observable universe (section simulation; right image) can count…
Read More